Equity Profile

AVTR

Avantor, Inc.

Health CareLife Sciences Tools & Services$9.4B

Jul31Fri

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Avantor, Inc. is a global provider of mission-critical products and services to customers in the life sciences and advanced technology sectors....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and is closely watched by investors.

Not available

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

AVTR Q2-2026 Earnings Preview

Context

Company Snapshot

Avantor, Inc. is a global provider of mission-critical products and services to customers in the life sciences and advanced technology sectors. Operating in the Health Care sector, Avantor plays a vital role in supporting scientific research and innovation, which is increasingly important as the demand for health care solutions continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+2.25%

Avg Stock Reaction

-9.02%

Last Quarter Recap

In Q1-2026, Avantor reported an EPS of $0.17, slightly beating estimates. However, the stock reacted negatively the following day, indicating market concerns.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's mixed performance in past quarters. The lack of analyst estimates adds uncertainty to expectations.

Bull Case

If Avantor can demonstrate strong revenue growth and maintain or improve its gross margins, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could exacerbate existing concerns and lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could impact stock performance.

How is Avantor managing its gross margins in the current economic environment?

Understanding margin management is essential, as it reflects the company's operational efficiency and pricing power.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Avantor's ability to leverage its recent investments in technology and innovation to drive growth.

Supporting Evidence

The company has a history of surprising on EPS, with a 63% beat rate over the last eight quarters.

Options pricing suggests a significant move, indicating that traders expect volatility, which could be a sign of underlying strength.

Recent trends in the life sciences sector indicate increased demand for Avantor's products and services.

Key Risk

If Avantor can report an EPS above $0.20, it could challenge the current cautious sentiment in the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Avantor's ability to improve profitability and manage costs in a competitive landscape.

Bull Confirmed If

An EPS of $0.20 or higher would confirm a bullish outlook, suggesting improved profitability.

Bear Confirmed If

An EPS below $0.15 would support a bearish view, indicating ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±22.75%

Historical Avg

±12.1%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±22.8% while AVTR has averaged ±12.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

47.4%

Calls (86K)P/C Ratio: 0.09Puts (388K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Avantor beats expectations, history suggests the stock could rise significantly, potentially around 3% on the first day.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a sharp decline, with historical patterns indicating an average drop of around 18%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on gross margins.
2Insights into demand trends for Avantor's products in the life sciences sector.
3Details on any new contracts or partnerships that could drive future revenue.
4Management's outlook on the competitive landscape and how it plans to differentiate itself.
5Responses to analyst questions regarding operational efficiencies and potential challenges.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul28

KNSABMO

Kiniksa Pharmaceuticals International, plc

PreviewView

Jul28

CURBBMO

Company Snapshot

Avantor, Inc. is a global provider of mission-critical products and services to customers in the life sciences and advanced technology sectors....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and is closely watched by investors.

Not available

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

AVTR Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+2.25%

Avg Stock Reaction

-9.02%

Last Quarter Recap

In Q1-2026, Avantor reported an EPS of $0.17, slightly beating estimates. However, the stock reacted negatively the following day, indicating market concerns.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's mixed performance in past quarters. The lack of analyst estimates adds uncertainty to expectations.

Bull Case

If Avantor can demonstrate strong revenue growth and maintain or improve its gross margins, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could exacerbate existing concerns and lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could impact stock performance.

How is Avantor managing its gross margins in the current economic environment?

Understanding margin management is essential, as it reflects the company's operational efficiency and pricing power.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Avantor's ability to leverage its recent investments in technology and innovation to drive growth.

Supporting Evidence

The company has a history of surprising on EPS, with a 63% beat rate over the last eight quarters.

Options pricing suggests a significant move, indicating that traders expect volatility, which could be a sign of underlying strength.

Recent trends in the life sciences sector indicate increased demand for Avantor's products and services.

Key Risk

If Avantor can report an EPS above $0.20, it could challenge the current cautious sentiment in the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Avantor's ability to improve profitability and manage costs in a competitive landscape.

Bull Confirmed If

An EPS of $0.20 or higher would confirm a bullish outlook, suggesting improved profitability.

Bear Confirmed If

An EPS below $0.15 would support a bearish view, indicating ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±22.75%

Historical Avg

±12.1%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±22.8% while AVTR has averaged ±12.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

47.4%

Calls (86K)P/C Ratio: 0.09Puts (388K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Avantor beats expectations, history suggests the stock could rise significantly, potentially around 3% on the first day.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a sharp decline, with historical patterns indicating an average drop of around 18%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on gross margins.
2Insights into demand trends for Avantor's products in the life sciences sector.
3Details on any new contracts or partnerships that could drive future revenue.
4Management's outlook on the competitive landscape and how it plans to differentiate itself.
5Responses to analyst questions regarding operational efficiencies and potential challenges.